CD133positive

CD133positive refers to a subset of cells that express the CD133 antigen, also known as prominin-1 or AC133. This antigen is a cell surface glycoprotein that plays a role in cell adhesion and signaling. CD133positive cells are characterized by their ability to self-renew and differentiate, making them a subject of interest in stem cell research.

CD133positive cells are found in various tissues, including the blood, bone marrow, and brain. In the context of cancer, CD133positive cells have been identified in several types of tumors, including breast, lung, and brain cancers. These cells are believed to contribute to tumor initiation, progression, and recurrence due to their stem cell-like properties.

Research on CD133positive cells has focused on their potential as a target for cancer therapy. Strategies include isolating and targeting these cells to prevent tumor growth and recurrence. Additionally, CD133positive cells have been studied for their potential in regenerative medicine, where they could be used to repair damaged tissues.

The exact mechanisms by which CD133positive cells function and their role in disease remain areas of active research. Understanding these aspects could lead to the development of new therapeutic approaches and advancements in tissue regeneration.